Pharmaceutical Business review

AcuNetx’s president and CEO resigns

Mr Waldorf’s position will be filled on an interim basis by Robert Corrigan, chairman of AcuNetx’s board and a seasoned executive with more than 25 years of experience in corporate finance and business development.

Mr Corrigan said: “I am enthusiastic and optimistic facing the challenge of building this company and am intent on growing sales, shoring up the balance sheet and strengthening our ties with the financial community.”

Exit mobile version